Aim(s): To evaluate the effectiveness of nursing interventions based on the lung cancer trajectory.
Background: The transition to the chronic state of lung cancer requires a shift in the management paradigm. Nurses are crucial in managing the health of patients with lung cancer through various services. Therefore, rigorous research is required to understand and provide evidence on the influence of nursing interventions.
Sources Of Evidence: We systematically selected studies on nursing interventions for patients with lung cancer published from 2000 to 2022 based on specific inclusion and exclusion criteria. A systematic review was conducted according to the Cochrane Handbook and PRIMA 2020 guidelines, and a meta-analysis was performed. The risk of bias in the included studies was evaluated using ROB 2.0.
Results: In this study, lung cancer trajectories were classified into diagnosis, treatment, survival, and end-of-life care based on a literature review. A meta-analysis of 47 nursing intervention studies involving 4852 patients confirmed the large effectiveness in significantly improving health-related quality of life, emotional symptoms, self-care behaviors, adjustment, satisfaction, health resource use, cost-effectiveness, and cancer symptoms. Only one study has been conducted on the end-of-life trajectory, highlighting the need for more nursing intervention research in this area.
Conclusions: Recent nursing experimental studies involving patients with lung cancer show small, large, and medium effect sizes during the diagnosis, treatment, and survival trajectories, respectively.
Implications For Nursing Practice And Research: A tailored nursing plan based on the disease trajectory is essential. Stakeholders should consider allocating resources to develop and strengthen nursing interventions, particularly at the diagnostic and end-of-life trajectories.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/inr.13074 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Enhancing Diagnostic Accuracy of Lung Nodules in Chest Computed Tomography Using Artificial Intelligence: Retrospective Analysis.
J Med Internet Res
January 2025
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Background: Uncertainty in the diagnosis of lung nodules is a challenge for both patients and physicians. Artificial intelligence (AI) systems are increasingly being integrated into medical imaging to assist diagnostic procedures. However, the accuracy of AI systems in identifying and measuring lung nodules on chest computed tomography (CT) scans remains unclear, which requires further evaluation.
View Article and Find Full Text PDFMetastasis stands as one of the most prominent prognostic factors in osteosarcoma. Over 70% of metastatic osteosarcoma occurrences affect the lung. Nonetheless, to date, there has been a scarcity of research addressing predictive factors for lung metastasis risk in osteosarcoma.
View Article and Find Full Text PDFSequential Proteomic and N-Glycoproteomic Analyses of Bronchoalveolar Lavage Fluids for Potential Biomarker Discovery of Lung Adenocarcinoma.
J Proteome Res
January 2025
The First Affiliated Hospital of Ningbo University, Ningbo315010, P.R. China.
Lung adenocarcinoma (LUAD) is the most common histological subtype of nonsmall-cell lung cancer. Herein, a multiomics method, which combined proteomic and N-glycoproteomic analyses, was developed to analyze the normal and cancerous bronchoalveolar lavage fluids (BALFs) from six LUAD patients to identify potential biomarkers of LUAD. The data-independent acquisition proteomic analysis was first used to analyze BALFs, which identified 59 differentially expressed proteins (DEPs).
View Article and Find Full Text PDFPatterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up.
Melanoma Manag
December 2024
Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH44195, USA.
This study determined the characteristics of patients with early-stage melanoma (IA-IIA) who later had stage IV recurrence. We retrospectively examined 880 melanoma patients and identified those who progressed to stage IV disease from an initial early-stage (n = 50). We observed a median latent period of 4 years between early-stage diagnosis and metastatic disease.
View Article and Find Full Text PDFEffects of early palliative care intervention on medical resource use among end-of-life patients.
Int J Qual Health Care
January 2025
Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, No. 666 Buzih Road, Taichung City 40601, Taiwan.
Background: In Taiwan, as the population ages, palliative care services (PCS) have expanded significantly to include comprehensive benefit plans for critically ill individuals, supported by reimbursements from the National Health Insurance program. However, incorporating palliative care into the medical management of these patients presents several challenges. We aim to evaluate the effects of palliative care interventions on medical resources in end-of-life scenarios, to promote earlier palliative care access and provide high-quality healthcare services for patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!